Change: -0.70 %Chge: -2.92% Vol: 5,022
ACOR Chart
You need Flash Player to see the chart, please download from the link below
Online News For Acorda Therapeutics
Could Acorda Therapeutics Inc (NASDAQ:ACOR) Change Direction After More Shorts?
Investors sentiment decreased to 0.99 in Q4 2017. Its down 0.23, from 1.22 in 2017Q3. It is negative, as 24 investors sold Acorda Therapeutics, Inc. shares while 46 reduced holdings. 23 funds opened positions while 46 raised stakes. 48.17 million shares or ...
Multi-storey timber buildings: A renaissance in timber construction
The Cabin, Mount Wilson. Designed by SJB Architects, structural engineering by ACOR Consulting. Image: Charles Peters 30 Murrain Street, designed by Thodey Design structural engineering by ACOR Consulting. Image: ACOR The shift away from concrete and steel ...
New Strong Sell Stocks for April 18th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: Acorda Therapeutics, Inc. ACOR is a developer of therapies for neurological disorders. The Zacks Consensus Estimate for its current year earnings has been revised 93.2% downward over ...
Eagle Asset Management Has Lowered Allison Transmission Holding (ALSN) Stake ...
Among 14 analysts covering Acorda Therapeutics (NASDAQ:ACOR), 5 have Buy rating, 1 Sell and 8 Hold. Therefore 36% are positive. Acorda Therapeutics had 45 analyst reports since August 25, 2015 according to SRatingsIntel. Piper Jaffray initiated Acorda ...
Want To Add This Quote To Your Site?
With our stock widgets you can add a Acorda Therapeutics quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ACOR to choose from. Visit here to build your stock quote widget »
